PlainRecalls
FDA Drug Moderate Class II Terminated

Asthmanefrin Racephinephrine Inhalation Solution Bronchodilator, For temporary relief of mild symptoms of intermittent asthma, Preservative Free, Sterile, For Oral Inhalation Only, 30 vials per box, Nephron Pharmaceuticals Corporation, NDC 0487-2784-01.

Reported: August 17, 2022 Initiated: June 29, 2022 #D-1324-2022

Product Description

Asthmanefrin Racephinephrine Inhalation Solution Bronchodilator, For temporary relief of mild symptoms of intermittent asthma, Preservative Free, Sterile, For Oral Inhalation Only, 30 vials per box, Nephron Pharmaceuticals Corporation, NDC 0487-2784-01.

Reason for Recall

CGMP Deviations: products were stored outside the drug label specifications.

Details

Units Affected
1 box
Distribution
Nationwide in the USA.
Location
Richmond, VA

Frequently Asked Questions

What product was recalled?
Asthmanefrin Racephinephrine Inhalation Solution Bronchodilator, For temporary relief of mild symptoms of intermittent asthma, Preservative Free, Sterile, For Oral Inhalation Only, 30 vials per box, Nephron Pharmaceuticals Corporation, NDC 0487-2784-01.. Recalled by Mckesson Medical-Surgical Inc. Corporate Office. Units affected: 1 box.
Why was this product recalled?
CGMP Deviations: products were stored outside the drug label specifications.
Which agency issued this recall?
This recall was issued by the FDA Drug on August 17, 2022. Severity: Moderate. Recall number: D-1324-2022.